Nostrum Laboratories has voluntarily recalled another lot of metformin HCl extended-release tablets 750 mg dosage, expanding their initial announcement in November 2020. According to the new notice, ...

(CNN) — Two lots of a widely used type 2 diabetes medication, metformin, are being recalled due to possible contamination with a potentially cancer-causing compound. Metformin is designed to lower ...

The drumbeat of US recalls continues for various lots of extended-release metformin due to contamination with unacceptably high levels of a nitrosoamine that pose a cancer risk. On December 28, Viona ...

Metformin, a medication to treat type 2 diabetes, is facing a recall over concerns it has been contaminated with a possible cancer-causing substance. Nostrum Laboratories Inc., the maker of Metformin, ...

Two lots of Type 2 diabetes drug metformin made by Bayshore Pharmaceuticals have been recalled for having more carcinogen NDMA than the FDA’s acceptable daily allowance. The lots were sold to ...

Following an initial recall in June, Marksans Pharma Limited has now issued an expanded recall for its Metformin Hydrochloride extended-release tablets because they may contain N-Nitrosodimethylamine ...

Marksans Pharma Limited of India has expanded a recall it issued in June for Metformin Hydrochloride Extended Release tablets prescribed for people with Type 2 diabetes. The recall includes an ...

Three makers of Type 2 diabetes drug Metformin announced recalls Friday, the U.S. Food & Drug Administration reported. The reason for the voluntary recalls: the U.S. Food & Drug Administration ...

JAN. 13 UPDATE: Viona re-announced this December recall on Friday, but to the consumer level instead of just the retail level. The 23 lots recalled are included in the 33 below. Viona says 10 lots ...

The U.S. Food and Drug Administration has asked some pharmaceutical companies to voluntarily recall extended-release metformin, a popular drug used to control high blood sugar in people with Type 2 ...

Following two other recalls from Apotox Corp. and Amneal Pharmaceuticals for the diabetes drug Metformin because of higher than acceptable levels of Nitrosodimethylamine (NDMA), a cancer-causing ...